Filing Details
Elevance Health, Inc. (NYSE:ELV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 15, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNYSE:ELV
Elevance Health, Inc. (ELV) Files Quarterly Report for Q0
Filing Details Elevance Health, Inc. (NYSE:ELV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 15, 2026. The Healthcare company…
Market Context
Elevance Health, Inc.'s stock currently trades at $390.33 with a market capitalization of $80.0B.
The 10-Q provides Elevance Health, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Elevance Health, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ELV Stock Page
Frequently Asked Questions
Where can I read ELV's SEC filings?
Browse all filings on our ELV SEC filings page.
What types of SEC filings does Elevance Health, Inc. file?
Public companies like Elevance Health, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
